'Mg day' presentation slideshows

Mg day - PowerPoint PPT Presentation


Foods to fill the iron and vitamin A gaps

Foods to fill the iron and vitamin A gaps

30/1 Foods to fill the iron and vitamin A gaps After completing this session participants will be able to: list the local foods that can fill the nutrient gaps for iron and vitamin A explain the importance of animal-source foods explain the importance of legumes

By Anita
(382 views)

Genetic polymorphism: (i) individual handling of drugs 	(ii) inherited susceptibility to disease

Genetic polymorphism: (i) individual handling of drugs (ii) inherited susceptibility to disease

Genetic polymorphism: (i) individual handling of drugs (ii) inherited susceptibility to disease. Much individuality in drug response is inherited (polymorphism). PHARMACOGENETICS. Identify specific genes associated with specific diseases and that may be targets for new drugs.

By thu
(446 views)

CONSTITUTIONAL SYMPTOMS

CONSTITUTIONAL SYMPTOMS

CONSTITUTIONAL SYMPTOMS. Reassurance Rest/exercise NSAID Antimalarials Steroids (e.g. Prednisone < .25 mg/kg/day) DHEA TCA/SSRI/Behavioral or cognitive therapy. CUTANEOUS. Sun avoidance/sunblock Steroids (topical and intralesional) Hydroxychloroquine (plaquenil) Chloroquine (aralen)

By stedman
(536 views)

LEPROSY.

LEPROSY.

LEPROSY. A chronic contagious disease primarily affecting the peripheral nerves secondarily involving skin, mucosa of mouth and upper respiratory tract, reticulo-endothelial system, eyes, bones and testes. Causative agent: Mycobacterium leprae.

By nusa
(942 views)

Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme

Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme

IMAGINE. Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme . Presented at The European Society of Cardiology Hot Line Session, September 2005 Presented by Dr. W H van Gilst . IMAGINE.

By ting
(226 views)

Using Opioids in the Hospitalized Patient

Using Opioids in the Hospitalized Patient

Using Opioids in the Hospitalized Patient. Nicole Artz, MD Assistant Professor of Medicine University of Chicago. No financial relationships to disclose. Outline. Rapid titration for rapid pain relief Dosing the PCA Converting between drug and route Special Populations

By shirlyn
(459 views)

Two Cases of Subconjunctival Bevacizumab Injection to Prevent Bleb Failure after Trabeculectomy

Two Cases of Subconjunctival Bevacizumab Injection to Prevent Bleb Failure after Trabeculectomy

Two Cases of Subconjunctival Bevacizumab Injection to Prevent Bleb Failure after Trabeculectomy. Dongwook Lee, Min Ahn, In-Cheon You, Daegyu Lee Chonbuk National University Medical School, Korea Authors have no financial interests in this presentation. Purpose.

By moanna
(201 views)

Charcot neuroarthropathy:

Charcot neuroarthropathy:

Charcot neuroarthropathy: . History.

By germain
(207 views)

ASCOT Lancet, April 2003 n=10,305

ASCOT Lancet, April 2003 n=10,305

ASCOT Lancet, April 2003 n=10,305. Evidence for: primary prevention of CHD and stroke in high risk , middle aged, hypertensive, male patients with TC <6.5mmol/L Questions remaining : women n=1942; adverse & long term effects;

By vinny
(95 views)

Cholesterol Metabolism

Cholesterol Metabolism

Cholesterol Metabolism . Objectives. Review the regulatory mechanisms of cholesterol metabolism Discuss various agents affecting cholesterol metabolism. Net Cholesterol Balance in Humans. Synthesized Cholesterol (900 mg/day). Fecal Sterols (1200 mg/day).

By briar
(261 views)

Vitamin C and B Vitamins

Vitamin C and B Vitamins

Vitamin C and B Vitamins. Background. Water soluble vitamins include the B-complex vitamins and vitamin C B vitamins associated with energy production Dissolve in water Excreted/not stored Need to replenish. Vitamin B 12. Sources Fortified breakfast cereal Foods that come from animals

By kaya
(113 views)

GIFT ACC/i2 2011

GIFT ACC/i2 2011

Primary Results From G enotype I nformation and F unctional T esting A Prospective Pharmacogenomic Analysis of Clopidogrel Therapy. GIFT ACC/i2 2011.

By conner
(122 views)

Simeprevir in Treatment –Experienced Genotype 1 ASPIRE Trial

Simeprevir in Treatment –Experienced Genotype 1 ASPIRE Trial

Phase 3. Treatment Experienced. Simeprevir in Treatment –Experienced Genotype 1 ASPIRE Trial. Z euzem S , et al. Gastroenterol . 2014;146:430-41. Simeprevir in Treatment Experienced Genotype 1 HCV ASPIRE Trial: Features. Source: Zeuzem S , et al. Gastroenterol . 2014;146:430-41.

By effie
(128 views)

Simeprevir with Peginterferon and Ribavirin in GT-4 RESTORE

Simeprevir with Peginterferon and Ribavirin in GT-4 RESTORE

Phase 3. Treatment Naïve and Treatment Experienced. Simeprevir with Peginterferon and Ribavirin in GT-4 RESTORE. Moreno C, et al. 49 th EASL. April 2014: Abstract P1319. Simeprevir + Peginterferon + Ribavirin in Genotype 4 RESTORE: Study Features.

By tanika
(199 views)

Simeprevir in HIV Coinfection, GT-1 C212 Trial

Simeprevir in HIV Coinfection, GT-1 C212 Trial

Phase 3. Treatment Naïve and Treatment Experienced. Simeprevir in HIV Coinfection, GT-1 C212 Trial. Dieterich D , et al. 21 st CROI. 2014: Abstract 24. Simeprevir + PEG + Ribavirin for HCV-HIV Coinfection C212 Trial: Study Features.

By tillie
(139 views)

CASE 2

CASE 2

CASE 2 . 48 yo man IVDU in past….last used 27 yrs ago Stable social situation Currently receiving social assistance with provincial drug coverage No comorbid disease. CASE 2 . Hepatitis C disease parameters Secondary workup negative…no co-infections HCVRNA 3.65 x 10E7 iu /ml

By lita
(94 views)

Normal bone architecture

Normal bone architecture

Normal bone architecture. Early osteoporotic changes. Loss of trabeculation Increased lacunar space. INVESTIGATIONS. Rule out other reasons ( Normal chemical parameters) Only investigation available to measure bone mass is Bone Mineral Density (BMD). PREVENTIVE AND THERAPEUTIC MEASURES.

By isleen
(80 views)

Case Presentation: Alcoholic Liver Disease (ALD) Prince Firm

Case Presentation: Alcoholic Liver Disease (ALD) Prince Firm

Case Presentation: Alcoholic Liver Disease (ALD) Prince Firm. Aicha Rais , Amos Meir, Aneela Nawaz , Anoop Jose, Catherine Taylor, Eleanor Jones- Snape , Iain Murphy, Shweta Ramkumar. Patient History: PC. F, 46 presented one week ago with diffuse pain and bloating of the abdomen

By haven
(364 views)

Need for and p revalence of separate g uidelines

Need for and p revalence of separate g uidelines

Acute Toxicity SCTL Issues. Need for and p revalence of separate g uidelines List of substances: Ba, Cu, CN - , F - , Ni, Phenol, V ( cadmium evaluated, default SCTL protective of acute tox too ) Ingestion rate: 10 grams one event ( 50x default ) Review of t ox values to be used

By awena
(56 views)

View Mg day PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Mg day PowerPoint presentations. You can view or download Mg day presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.